To determine the changes of ROCK1 expression and activity throughout the pathological process of AD, we analyzed the mRNA expression, protein level and kinase activity of ROCK1 in the hippocampus of WT and APP/PS1 mice at 3, 6, 9, and 12 months of age (Fig. 1a). This evidence concerns the gene APP and Alzheimer disease.